{"commentary":{"count":3,"free_build_floor":8,"listing_floor":3,"by_channel":{"x_thread":3},"note":"Indexed podcasts, YouTube videos and X posts that name this trial. A report screens them, searches for more and cites what clinicians said when it is built."},"free_build":{"available":false},"name":"NCT06437509","nct_id":"NCT06437509","offer":{"currency":"USD","how":"Order at https://www.erudio.com/contact?report=nct06437509. The price is fixed at order. We build the report after the order and deliver it when it passes our checks; if it cannot be built to our standard, nothing is charged.","price_usd":750,"size":"focused","size_rule":"Focused: 1–12 commentary sources"},"registry":{"acronym":null,"arms":[{"description":"Participants receive BL-B01D1 + PD-1 monoclonal antibody as intravenous infusion for the first cycle (3 weeks). Participants with clinical benefit could receive additional treatment for more cycles. The administration will be terminated because of disease progression or intolerable toxicity occurring or other reasons.","label":"Study treatment","type":"EXPERIMENTAL"}],"collaborators":["Baili-Bio (Chengdu) Pharmaceutical Co., Ltd."],"completion_date":{"date":"2027-12","type":"ESTIMATED"},"conditions":["Extensive-stage Small-cell Lung Cancer"],"enrollment":{"count":66,"type":"ESTIMATED"},"has_results":false,"interventions":[{"name":"BL-B01D1","type":"DRUG"},{"name":"PD-1 monoclonal antibody","type":"DRUG"}],"last_update":"2026-07-23","lead_sponsor":"Sichuan Baili Pharmaceutical Co., Ltd.","official_title":"A Phase II Clinical Trial to Evaluate the Efficacy and Safety of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Extensive-stage Small Cell Lung Cancer","overall_status":"RECRUITING","phases":["PHASE2"],"primary_completion_date":{"date":"2026-12","type":"ESTIMATED"},"primary_outcomes":[{"measure":"Objective Response Rate (ORR)","timeFrame":"Up to approximately 24 months"},{"measure":"Recommended Phase II Dose (RP2D)","timeFrame":"Up to approximately 24 months"}],"references":[],"start_date":{"date":"2024-06-13","type":"ACTUAL"},"study_type":"INTERVENTIONAL","title":"A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Extensive-stage Small Cell Lung Cancer","url":"https://clinicaltrials.gov/study/NCT06437509"},"report":null,"schema_id":"erudio.trial_listing","schema_version":"2.0","state":"listed","state_text":"No report yet. It can be ordered.","url":"https://www.erudio.com/trials/nct06437509"}